-
Signature
-
/s/ Keely Stewart, under Power of Attorney dated April 17, 2023, from William Meaney
-
Stock symbol
-
IRM
-
Transactions as of
-
Jul 13, 2023
-
Transactions value $
-
-$1,243,398
-
Form type
-
4
-
Date filed
-
7/17/2023, 04:37 PM
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
IRM |
Common Stock, par value $.01 per share |
Options Exercise |
$326K |
+10.5K |
+3.55% |
$31.01 |
306K |
Jul 13, 2023 |
Direct |
F1 |
| transaction |
IRM |
Common Stock, par value $.01 per share |
Sale |
-$625K |
-10.5K |
-3.43% |
$59.45 |
296K |
Jul 13, 2023 |
Direct |
F1 |
| transaction |
IRM |
Common Stock, par value $.01 per share |
Options Exercise |
$326K |
+10.5K |
+3.55% |
$31.01 |
306K |
Jul 14, 2023 |
Direct |
F1 |
| transaction |
IRM |
Common Stock, par value $.01 per share |
Sale |
-$619K |
-10.5K |
-3.43% |
$58.89 |
296K |
Jul 14, 2023 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
IRM |
Employee Stock Option (Right to Buy) |
Options Exercise |
-$326K |
-10.5K |
-8.33% |
$31.01 |
116K |
Jul 13, 2023 |
Common Stock |
10.5K |
$31.01 |
Direct |
F2 |
| transaction |
IRM |
Employee Stock Option (Right to Buy) |
Options Exercise |
-$326K |
-10.5K |
-9.09% |
$31.01 |
105K |
Jul 14, 2023 |
Common Stock |
10.5K |
$31.01 |
Direct |
F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: